Seroprevalence and Epidemiology of Chikungunya with It’s Seasonal Trends Diagnosed at Tertiary Care Hospital, Ahmedabad.
A Comparative Evaluation On Mandibular Movements
DOI:
https://doi.org/10.70284/njirm.v8i2.1191Keywords:
Chikungunya, seroprevalence, epidemiology, IgM antibodyAbstract
Background & Objectives: To know the seroprevalence, epidemiological and seasonal trends of Chikungunya infection diagnosed at tertiary care hospital, Ahmedabad, Gujarat, India. Methods: A retrospective observational study was conducted at tertiary care hospital, Ahmedabad. A total of 1460 blood samples from suspected cases of Chikungunya were received from different wards, nearby primary and community health centers and district hospitals from duration of September 2015 to mid-November 2016. Patients’ medical records were screened for further information regarding the clinical presentation. All were tested for IgM antibody using ELISA at tertiary care hospital Ahmedabad. Results: Out of total 1460 cases, 241 (16.5%) were positive for IgM antibodies. Adults in the age group of 31years to 60 years (46.89%) were the mostly affected than any other age. Cases were presented with symptoms mainly of fever, joint pain, headache, body ache and joint swelling. Maximum cases were reported from duration of September to December, with female preponderance (63.9 %). Conclusion: Seroprevalence of Chikungunya is high in late monsoon season with middle age group and female preponderance. Although the Chikungunya disease is self limiting, treatment is symptomatic and supportive; morbidity can be very high resulting in a heavy social and economic toll. Proper diagnosis and prevention by educating the community & vector control measures appear to be the best approach at controlling Chikungunya fever. [Kinnari S NJIRM 2017; 8(2):20-22]
References
2. Schuffenecker I, Iteman I, Michault A, Murri S, Frangeul L, Vaney MC, et al. Genome microevolution of chikungunya viruses causing the Indian Ocean outbreak. PLoS Med.2006;3:e263.
3. Sam IC, Chua CL, Chan YF. Chikungunya virus diagnosis in the developing world: A pressing need. Expert Rev Anti Infect Ther. 2011;9:1089-91.
4. Kaur P, Ponniah M, Murhekar MV, Ramachandran V, Ramachandran R, Raju HK, et al. Chikungunya outbreak, South India,2006. Emerg Infect Dis. 2008;14:1623-5.
5. Balasubramaniam SM, Krishnakumar J, Stephen T, Gaur R, Appavoo N. Prevalence of chikungunya in urban field practice area of a private medical college, Chennai. Indian J Community Med. 2011;36:124-7.
6. Dwibedi B, Sabat J, Mahapatra N, Kar SK, Kerketta AS, Hazara RK, et al. Rapid spread of chikungunya virus infection in Orissa: Indian J Med Res. 2011;133:316-21.
7. Chandra P, Das B, Sowmya MK, Samanta S, Thimmaraju KV. Epidemiological study on chikungunya outbreak in Manglore district, Karnataka. Int J Pharma Bio Sci. 2011;2:343-7.
8. Mohan A, Kiran DH, Manohar IC, Kumar DP. Epidemiology, clinical manifestations, and diagnosis of chikungunya fever: Lessons learned from the re-emerging epidemic. Indian J Dermatol. 2010;55:54-63.
9. Ray P, Ratagiri VH, Kabra SK, Lodha R, Sharma S, Sharma BS, et al. Chikungunya infection in India: Results of a prospective hospital based multi-centric study. PLoS One. 2012;7:e30025.
10. Murhekar MV, Manickam P, Kumar RM, Ganesakumar SR, Ramachandran V, Ramakrishnan R, et al. Treatment practices and laboratory investigations during chikungunya outbreaks in South India. Indian J Med Res. 2011;133:546-7.
11. Lata Baswanna Galate, Sachee R Agrawal, Jayanthi S Shastri, Vikram Londhey. Chikungunya fever among patients with acute febrile illness attending a tertiary care hospital in Mumbai. J Lab Physicians, 2016 Jul-Dec;8(2):85-89.
12. Indrani Mohanty, Muktikesh Dash, Susmita Sahu, M V Narasimham. Seroprevalence of chikungunya
13. in Southern Odisha. J Family Med Prim Care 2013 jan;2(1)33-6
